MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells From Melanoma Patients

PLoS ONE - United States
doi 10.1371/journal.pone.0051716
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Identification of CD4+ T Cell Epitopes From NY-ESO-1 Presented by HLA-DR Molecules

Journal of Immunology
AllergyImmunology
2000English

The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors

Journal of Immunology
AllergyImmunology
2015English

Induction of CD4+ Th1 Lymphocytes That Recognize Known and Novel Class II MHC Restricted Epitopes From the Melanoma Antigen Gp100 by Stimulation With Recombinant Protein

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2004English

HLA Class II-Restricted CD8+ T Cells in HIV-1 Virus Controllers

Scientific Reports
Multidisciplinary
2019English

CD4+ Regulatory T Cell Responses Induced by T Cell Vaccination in Patients With Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Nonclassical Antigen-Processing Pathways Are Required for MHC Class II-Restricted Direct Tumor Recognition by NY-ESO-1-Specific CD4+ T Cells

Cancer immunology research
Cancer ResearchImmunology
2013English

High Frequency of T Cells Specific for Cryptic Epitopes in Melanoma Patients

OncoImmunology
OncologyAllergyImmunology
2013English

Detection of GAD65 Autoreactive T-Cells by HLA Class I Tetramers in Type 1 Diabetic Patients

Journal of Biomedicine and Biotechnology
2009English

Human CD4+ T Cells Specifically Recognize a Shared Melanoma-Associated Antigen Encoded by the Tyrosinase Gene.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy